Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
- 14 June 1990
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (24) , 1693-1699
- https://doi.org/10.1056/nejm199006143222402
Abstract
Anemia is a common complication of multiple myeloma. It resolves early in the disease if chemotherapy induces a complete remission, but persists if the disease progresses, causing disabling symptoms and often requiring blood transfusions.Keywords
This publication has 26 references indexed in Scilit:
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: Clinical and in vitro studiesArthritis & Rheumatism, 1989
- The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietinKidney International, 1989
- Evaluation of the stability of human erythropoietin in samples for radioimmunoassayJournal of Molecular Medicine, 1988
- Erythropoietin Coming of AgeNew England Journal of Medicine, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Bone Marrow Erythropoiesis in the Anemia of Infection, Inflammation, and MalignancyJournal of Clinical Investigation, 1974
- On the in vivo action of erythropoietin: a quantitative analysisJournal of Clinical Investigation, 1972
- Blood volume and hematocrit value in macroglobulinemia and myelomaArchives of internal medicine (1960), 1969